Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A concise primer on initial crypto choices, risk awareness, and how to approach your first investment with clarity.
19,614 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
When a state tightens its grip on fraud, honest families feel the impact first. Alaska's Medicaid crackdown underscor...
Jeff Bezos-led Blue Origin plans a $10 billion external round at a $130 billion valuation, a move that reframes priva...
June card spending rose 6.3% year over year, with wage gains across all income groups. The latest bofa consumer chief...
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
AI-driven demand for high-bandwidth memory is squeezing the global supply, raising costs for devices and testing Appl...
Nike's latest sponsorship moves suggest a gradual return of brand influence and profit potential. This article explor...
A 64-year-old worker was laid off and wrongly believed his severance forced early Social Security filing. The mistake...
A new study links higher grocery costs to growing credit-card use at checkout, signaling widening financial strain fo...
Non-China emerging markets have moved to the forefront of global returns in 2026, delivering double-digit gains even ...
Money isn’t just numbers—it's a team sport. Learn how mib: douglas heather boneparth approach investing as a couple, ...
As retail faces slower discretionary spend, Walmart doubles down on automation, ads, and marketplace scale, while Cos...